The top two are for scolds.
Point is Avita now have a product they can market and as the public become aware that ReCell is gold standard FDA approved care enrollment should be a lot faster.
Venous leg ulcers is a mega care market.
Well done Bread,
MB
Ongoing clinical trials, page-2
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
-0.020(0.81%) |
Mkt cap ! $167.5M | |||
| Open | High | Low | Value | Volume |
| $2.47 | $2.49 | $2.44 | $269.3K | 109.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4244 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 50 | 1 |
View Market Depth
| Last trade - 14.09pm 11/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |